LGND INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ligand Pharmaceuticals Inc...

NEW YORK, Jan. 4, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Ligand Pharmaceuticals Inc. (NASDAQ: LGND) securities between November 9, 2015 and November 14, 2016.

Click here to learn about the case: http://www.wongesq.com/pslra/ligand-pharmaceuticals. There is no cost or obligation to you.

According to the complaint, during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Ligand overstated the value of certain Deferred Tax Assets by approximately $27.5 million; (2) Ligand's outstanding convertible senior unsecured notes due 2019 should have been classified as short-term debt rather than long-term debt as of December 31, 2015; (3) Ligand did not maintain effective controls over the accuracy and presentation of the accounting for income taxes related to complex transactions; (4) in turn, Ligand lacked effective internal control over financial reporting; and (5) as a result, Defendants' statements about Ligand's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in Ligand you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [e-mail], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/ligand-pharmaceuticals.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:   
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. [phone]
Fax. [phone]
E-Mail: [e-mail]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lgnd-investor-alert-the-law-offices-of-vincent-wong-reminds-investors-of-a-class-action-involving-ligand-pharmaceuticals-inc-and-a-lead-plaintiff-deadline-of-january-17-2017-300385642.html

SOURCE The Law Offices of Vincent Wong

Copyright 2017 PR Newswire